Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company focused on high-need, targeted therapeutic areas, announces the completion of its combination with Radius Health, Inc., adding the osteoporosis therapy TYMLOS® (abaloparatide) to its growing commercial portfolio of differentiated specialty medicines. Paratek is a specialty pharmaceutical platform company with a portfolio of diverse, innovative medicines well positioned for long-term growth. The company integrates and advances assets through disciplined commercial execution, lifecycle management, and clinical development, with a proven track record of integrating and growing pharmaceutical assets across multiple therapeutic areas.
Read the full article: Paratek Pharmaceuticals Completes Combination with Radius Health //
Source: https://www.globenewswire.com/news-release/2026/03/18/3258017/0/en/Paratek-Pharmaceuticals-Completes-Combination-with-Radius-Health-Expanding-Its-Multi-Product-Specialty-Commercial-Platform.html?_gl=1*wyc5ve*_up*MQ..*_ga*OTYyNTU1MjMxLjE3NzM4MzE3NjU.*_ga_B6167QB2TF*czE3NzM4MzE3NjQkbzEkZzAkdDE3NzM4MzE3NjQkajYwJGwwJGgw*_ga_ERWPGTJ5X8*czE3NzM4MzE3NjQkbzEkZzAkdDE3NzM4MzE3NjQkajYwJGwwJGgw